INTERNATIONAL PATENT: MAPLIGHT THERAPEUTICS, INC. FILES APPLICATION FOR "GPR6 INVERSE AGONISTS"

GENEVA, Aug. 6 -- MAPLIGHT THERAPEUTICS, INC. (800 Chesapeake DriveRedwood City, California 94063) filed a patent application (PCT/US2025/012537) for "GPR6 INVERSE AGONISTS" on Jan 22, 2025. With publication no. WO/2025/160132, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SYLVESTER, Mark (c/o MapLight Therapeutics, Inc.800 Chesapeake DriveRedwood City, California 94063)

Abstract: Provided herein, is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein Ra, Rb, Rc, Rd, X, Y, Cy, Hy and Z ar...